Transdermal Analgesic Patch Market 4.3% CAGR: Top Companies in 2025 According to a newly published market research report by 24LifeSciences, global transdermal analgesic patch market was valued at USD 6.5 billion in 2024 and is projected to reach USD 9.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2032 Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13888/transdermal-analgesic-patch-market

Dental Gypsum Powder Market to Grow at a CAGR of 5.7% Through 2032 According to a newly published market research report by 24LifeSciences, global dental gypsum powder market was valued at USD 50 million in 2024 and is projected to reach USD 73.9 million by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4506/dental-gypsum-powder-market

Pharmacy Automation Systems Market 5.8% CAGR: Top Companies in 2025 According to a newly published market research report by 24LifeSciences, the global Pharmacy Automation Systems market was valued at USD 3.06 billion in 2024 and is projected to reach USD 4.51 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7510/pharmacy-automation-systems-market

Hospital Acquired Infection Treatment Market to Grow at a CAGR of 1.7% Through 2032 According to a newly published market research report by 24LifeSciences, global Hospital Acquired Infection Treatment market was valued at USD 18.34 billion in 2024 and is projected to reach USD 20.62 billion by 2032, growing at a compound annual growth rate (CAGR) of 1.7% during the forecast period 2025–2032. Hospital Acquired Infections (HAIs), clinically referred to as nosocomial infections, are infections acquired by patients during the course of receiving treatment for other conditions within healthcare facilities, presenting a significant challenge to patient safety worldwide. These infections encompass a range of serious conditions including urinary tract infections, surgical site infections, bloodstream infections, and ventilator-associated pneumonia, among others. The treatment landscape is multifaceted, involving advanced antimicrobial agents, antiseptics, and specialized medical devices designed to combat these pathogens and improve patient outcomes in clinical settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9478/hospital-acquired-infection-treatment-market

Global Digestive Health Supplements Market Analysis & Future Opportunities According to a newly published market research report by 24LifeSciences, global digestive health supplements market was valued at USD 11.2 billion in 2024 and is projected to reach USD 19.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14047/digestive-health-supplements-market

Monkeypox Test Kit Market Size, Share & Revenue Outlook 2032 According to a newly published market research report by 24LifeSciences, the global Monkeypox Test Kit market was valued at USD 896.2 million in 2024 and is projected to reach USD 1.54 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13133/monkeypox-test-kit-market

Targeted Drug Delivery System Market Estimated to Experience a Hike in Growth by 2035 Roots Analysis recently published a report on the global Targeted Drug Delivery Device Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories. Market Size and Forecast Current Market Size:$427 Million Future Market Size: $2,153 Million CAGR: CAGR of 19.7% Market Overview This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration. Market Scope and Segmentation - Forecast Period: Till 2035 - Market Size in 2026: $427 Million - Market Size in 2035: $2,153 Million - Growth Rate: CAGR of 19.7% - Type of Device • Cannula • Catheter • Others - Type of Organ • Brain • Breast • Eyes • Heart - Type of Therapy Delivered • Cell Therapy • Gene Therapy • Immunotherapy - Route of Administrtaion • Intratumoral • Transendocardial • Others - Therapeutic Area • Cardiovascular Disorders • Oncological Disorders • Opthalmic Disorders • Neurological Disorders - Geographical Regions • North America • Europe • Asia-Pacific - Key Companies Profiled • Alcyone Lifesciences • Algorae Pharmaceuticals • ClearPoint Neuro • Gloriana Therapeutics • Mercator MedSystems • Neurotech Pharmaceuticals • Novartis • OncoSec • PharmaCyte Biotech • PulseSight Therapeutics • Renishaw • Silexion Therapeutics • SmartCella - PowerPoint Presentation(Complimentary): Available - Customization Scope: 15% Free Customization - Excel Data Packs(Complimentary) • Market Landscape • Clinical Trial Analysis • Likely Drug Candidates • Market Forecast and Opportunity Analysis Read More:https://www.rootsanalysis.com/reports/targeted-drug-delivery.html By Region North America, Europe, Asia-Pacific This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities. Technological and Strategic Insights The Roots Analysis report includes a detailed assessment of: Technological advancements and R&D activity Innovations in formulation and delivery methods Marketing and distribution strategies Pricing models and cost structures Manufacturing capacities and supply chain trends These insights are presented neutrally, supported by empirical evidence and primary research validation. Key Market Players Profiles of prominent companies include: Alcyone Lifesciences, Algorae Pharmaceuticals, ClearPoint Neuro, Gloriana Therapeutics, Mercator MedSystems, Neurotech Pharmaceuticals, Novartis, OncoSec, PharmaCyte Biotech, PulseSight Therapeutics, Renishaw, Silexion Therapeutics, SmartCella Each profile highlights: Product portfolio and focus areas Operational footprint and regional presence Financial and strategic performance Recent developments (e.g., partnerships, market entries, acquisitions) Regional Insights Each region is analyzed based on: Historical and current market size Revenue performance Contribution to global share Strategic developments and regional trends Comparative insights across regions enable targeted market entry and expansion strategies. Report Structure Part 01: Market Overview Part 02: Market Size, by Regions Part 03: Market Revenue, by Countries Part 04: Market Competition, by Key Players Part 05: Company Profiles

Blood Bank (Blood Banking) Market Forecast 2026–2034: Trends & Insights According to a newly published market research report by 24LifeSciences, the global blood bank (blood banking) market was valued at USD 19,430 million in 2024 and is projected to reach USD 31,370 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6795/blood-bank-blood-banking-market

Global Doxorubicin Hydrochloride Liposome Injection Market to Reach USD 2.9 Billion by 2034 According to a newly published market research report by 24LifeSciences, the global doxorubicin hydrochloride liposome injection market was valued at USD 1.8 billion in 2025 and is projected to reach USD 2.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2026–2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14612/doxorubicin-hydrochloride-liposome-injection-market

Global Progressive Multifocal Leukoencephalopathy Treatment Market to Reach USD 7.2 Billion by 2032 According to a newly published market research report by 24LifeSciences, global Progressive Multifocal Leukoencephalopathy Treatment market was valued at USD 380 million in 2024 and is projected to reach USD 650 million by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15890/progressive-multifocal-leukoencephalopathy-treatment-market

Pulmonary Drug Delivery Systems Market to Grow at a CAGR of 4.5% Through 2032 According to a newly published market research report by 24LifeSciences, global pulmonary drug delivery systems market was valued at USD 2,908 million in 2024 and is projected to reach USD 3,941 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7673/pulmonary-drug-delivery-systems-market

Modular Operation Theater Market to Grow at a CAGR of 8.9% Through 2032 According to a newly published market research report by 24LifeSciences, global modular operation theater market was valued at USD 315 million in 2024 and is projected to reach USD 564 million by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2024–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4622/modular-operation-theater-market